MedTrace Logo

DeNovo NT Longitudinal Data Collection (LDC) Knee Study

NCT01329445 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2017-01-26

No results posted yet for this study

Summary

The purpose of this study is to evaluate the long-term outcomes of DeNovo NT, a tissue product used for the repair of cartilage damage in the knee. This product has been on the market since 2007 and implanted in more than 10,000 patients around the country.

Conditions

  • Degenerative Lesion of Articular Cartilage of Knee
  • Osteochondritis Dissecans

Interventions

OTHER

DeNovo NT, Natural Tissue Graft

DeNovo NT Natural Tissue Graft of 1 or 2 lesions up to 5 cm squared in area.

Sponsors & Collaborators

  • Zimmer Orthobiologics, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01329445 on ClinicalTrials.gov